A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HPS / hepatopulmonary syndrome

[Related PubMed/MEDLINE]
Total Number of Papers: 381
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HPS  (>> Co-occurring Abbreviation)
Long Form:   hepatopulmonary syndrome
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 A 10-year-old boy with dyspnea and hypoxia: abernathy malformation masquerading as pulmonary arteriovenous fistula. IVC, MPV, PAVF, SHUNT, SMV
2019 Cyclooxygenase-2 regulates HPS patient serum induced-directional collective HPMVEC migration via PKC/Rac signaling pathway. COX-2, HPMVECs
2019 Effect of Transjugular Intrahepatic Portosystemic Shunt Creation on Pulmonary Gas Exchange in Patients with Hepatopulmonary Syndrome: AProspective Study. TIPS
2019 Effects of Caffeine Treatment on Hepatopulmonary Syndrome in Biliary Cirrhotic Rats. CBDL
2019 Evidence for an Association Between Intrahepatic Vascular Changes and the Development of Hepatopulmonary Syndrome. ---
2019 Extracorporeal Membrane Oxygenation in a Pediatric Patient with Hepatopulmonary Syndrome and Interrupted Inferior Vena Cava After Living Related Liver Donation. ECMO
2019 Prevalence and characteristics of hepatopulmonary syndrome in children with cirrhosis in southern Brazil. CE-TTE, IPVDs, Tc-MMA
2019 Pulmonary Hypertension that Developed During Treatment for Hepatopulmonary Syndrome and Pulmonary Arteriovenous Malformation. PAVM, PH
2019 Pulse Oximetry Is Insensitive for Detection of Hepatopulmonary Syndrome in Patients Evaluated for Liver Transplantation. CE, CI, LT
10  2019 Sorafenib in Hepatopulmonary Syndrome (SHPS): A Randomized, Double-Blind Placebo-Controlled Trial. SHPS
11  2018 A case report of hepatopulmonary syndrome in hereditary hemorrhagic telangiectasia (HHT): Not all right-to-left shunting in HHT is due to pulmonary arteriovenous malformations. AVMs, HHT, PAVMs
12  2018 A subclinical high tricuspid regurgitation pressure gradient independent of the mean pulmonary artery pressure is a risk factor for the survival after living donor liver transplantation. LDLT, mPAP, OLT, PH, POPH, TRPG
13  2018 Acute right ventricular failure after orthotopic liver transplantation. CO, ESLD, OHT, PoPHTN
14  2018 AMD3100 treatment attenuates pulmonary angiogenesis by reducing the c-kit (+) cells and its pro-angiogenic activity in CBDL rat lungs. CBDL
15  2018 An Unusual Case of Refractory Hypoxia on the ICU. ---
16  2018 Changes in arterial oxygenation after portal decompression in Budd-Chiari syndrome patients with hepatopulmonary syndrome. BCS, TIPS
17  2018 Clinical Impact of Intrapulmonary Vascular Dilatation in Candidates for Liver Transplant. A-a, IPVD, IQR
18  2018 Correlations of MMP-2 and MMP-9 gene polymorphisms with the risk of hepatopulmonary syndrome in cirrhotic patients: A case-control study. PCR-RFLP
19  2018 Different forms of pulmonary hypertension in a family with clinical and genetic evidence for hereditary hemorrhagic teleangectasia type 2. AVMs, HPAH, HTT, PAH, PH, PoPAH
20  2018 Hepatopulmonary Syndrome in Children: A 20-Year Review of Presenting Symptoms, Clinical Progression, and Transplant Outcome. LT, PICU
21  2018 Impact of Bacterial Translocation on Hepatopulmonary Syndrome: A Prospective Observational Study. LBP, LPS
22  2018 Mild to Moderate Intrapulmonary Shunting in Pediatric Liver Transplantation: Is Screening Necessary? IPVS, LT
23  2018 miR144-3p inhibits PMVECs excessive proliferation in angiogenesis of hepatopulmonary syndrome via Tie2. miRNAs, PMVECs, Tie2
24  2018 Placental growth factor inhibition targets pulmonary angiogenesis and represents a therapy for hepatopulmonary syndrome in mice. CBDL, PlGF
25  2018 Potential Clinical Targets in Hepatopulmonary Syndrome: Lessons From Experimental Models. ---
26  2018 Pulmonary arteriovenous malformations: diagnosis. CT, HHT, PAVMs, TTCE
27  2018 Pulmonary transit time derived from pulmonary angiography for the diagnosis of hepatopulmonary syndrome. PTT
28  2018 Raised plasma levels of H2S and nitrate predict intrapulmonary vascular dilations: A preliminary report in patients with cryptogenic cirrhosis. IPVD
29  2018 Review article: Update on current and emergent data on hepatopulmonary syndrome. ---
30  2018 Screening for Hepatopulmonary Syndrome in Cirrhotic Patients Using Technetium 99m-macroaggregated Albumin Perfusion Lung Scan (Tc-MAA): Diagnostic Approach and Clinical Correlations. ---
31  2018 Time-dependent reversal of significant intrapulmonary shunt after liver transplantation. CE, CI, IPS, LT, OR
32  2018 Why Pulse Oximetry Is Inaccurate in Liver Cirrhosis: Ancient Knowledge. ---
33  2018 [Hepatopulmonar syndrome and liver transplantation: experience in the transplantation department of the Guillermo Almenara Irigoyen National Hospital - EsSalud]. ---
34  2018 [Liver diseases and pulmonary vascular disorders]. PAH, PAP, POPH, PVR, WU
35  2017 Annexin A2-modulated proliferation of pulmonary arterial smooth muscle cells depends on caveolae and caveolin-1 in hepatopulmonary syndrome. ANXA2, MbetaCD, PASMCs
36  2017 Clinical efficacy of transjugular intrahepatic portosystemic shunt in the treatment of hepatopulmonary syndrome. TIPS
37  2017 CXCR2 is involved in pulmonary intravascular macrophage accumulation and angiogenesis in a rat model of hepatopulmonary syndrome. CBDL, ERK, MAP, PVP, TNF-alpha, vWF
38  2017 Cyclooxygenase-2 promotes pulmonary intravascular macrophage accumulation by exacerbating BMP signaling in rat experimental hepatopulmonary syndrome. BMP-2, CBDL, CV-2, PMVECs
39  2017 Diammonium glycyrrhizinate alleviates hepatopulmonary syndrome via restoring superoxide dismutase 3 activity in rats. DG, nNOS, NO, SOD3
40  2017 Differential diagnosis of hepatopulmonary syndrome (HPS): Portopulmonary hypertension (PPH) and hereditary hemorrhagic telangiectasia (HHT). HHT, PPH
41  2017 Disparities in Eurotransplant liver transplantation wait-list outcome between patients with and without model for end-stage liver disease exceptions. BS, ET, HCC, MELD, NSEs, PCLD, PPH, PSC, SEs
42  2017 Extracorporeal membrane oxygenation for post-transplant hypoxaemia following very severe hepatopulmonary syndrome. ECMO
43  2017 Good for the lung but bad for the liver? Garlic-induced hepatotoxicity following liver transplantation. ---
44  2017 Hepatopulmonary Syndrome and Portopulmonary Hypertension: Implications for Liver Transplantation. OLT, POPH
45  2017 Hepatopulmonary syndrome is associated with the presence of hepatocellular carcinoma in patients with decompensated cirrhosis. CI, OR
46  2017 Hepatopulmonary syndrome with large pulmonary arteriovenous malformations: CT findings with emphasis on its association with a mosaic pattern of the lung parenchyma. CT, PAVM
47  2017 Hepatopulmonary syndrome: which blood gas analysis criteria and position should we use for diagnosis? LT
48  2017 Isolated Intrapulmonary Vascular Dilatations and the Risk of Developing Hepatopulmonary Syndrome in Liver Transplant Candidates. CE, IPVD, LT
49  2017 Late complications of biliary atresia: hepatopulmonary syndrome and portopulmonary hypertension. BA, PPH
50  2017 MIR196A2 rs11614913 C>T polymorphism correlates with an increased risk of hepatopulmonary syndrome in liver cirrhosis: a case-control study in China. MIR196A2
51  2017 Onset ages of hepatopulmonary syndrome and pulmonary hypertension in patients with biliary atresia. BA, POPH
52  2017 Prolonged Unexplained Hypoxemia as Initial Presentation of Cirrhosis: A Case Report. NASH
53  2017 Schistosomiasis and hepatopulmonary syndrome: the role of concomitant liver cirrhosis. HSS, MELD
54  2017 Selective cyclooxygenase inhibition by SC-560 improves hepatopulmonary syndrome in cirrhotic rats. CBDL, COX
55  2017 Severe Hepatopulmonary Syndrome in a Child with Caroli Syndrome. PELD
56  2017 The effects of pioglitazone in cirrhotic rats with hepatopulmonary syndrome. CBDL, eNOS, NO, VEGF
57  2017 The ET-1-mediated carbonylation and degradation of ANXA1 induce inflammatory phenotype and proliferation of pulmonary artery smooth muscle cells in HPS. ANXA1, ET-1, PASMCs, PVR
58  2017 The utility of the macro-aggregated albumin lung perfusion scan in the diagnosis and prognosis of hepatopulmonary syndrome in cirrhotic patients candidates for liver transplantation. LT
59  2017 Unexplained cyanosis caused by hepatopulmonary syndrome in a girl with APECED syndrome. AIRE, APECED
60  2017 Waitlist Outcomes for Patients Relisted Following Failed Donation After Cardiac Death Liver Transplant: Implications for Awarding Model for End-Stage Liver Disease Exception Scores. DCD, E-RL, HAT, HCC, L-RL, LT, PNF
61  2017 [Clinical and laboratory characteristics of patients with pulmonary hypertension and pulmonary vascular complications hospitalized at the Instituto Nacional de Salud del Nino]. PHT, PPHN
62  2017 [Hepatopulmonary syndrome and portopulmonary hypertension]. POPH
63  2017 [Prevalence and severity of the hepatopulmonar syndrome in patients with liver cirrhosis attended at Cayetano Heredia Hospital, between January and December 2015]. HCH, LC
64  2016 A case report of suspected hepatopulmonary syndrome secondary to ductal plate malformation with chronic active hepatitis in a dog. ---
65  2016 Anesthesia for liver transplantation. BIS, ESLD, ICP, IVC, LVOTO, MELD, ONSD, POPH, PRS, TCD, TEE, TEG, VVBP
66  2016 Annexin A2 inhibits the migration of PASMCs stimulated with HPS rat serum by down-regulating the expression of paxillin. ANXA2, CBDL, IPVD, PASMCs, PVR
67  2016 Autoimmune hepatitis in a child presenting with hepatopulmonary syndrome (HPS). ---
68  2016 Congenital extrahepatic portosystemic shunt: an underdiagnosed but treatable cause of hepatopulmonary syndrome. CEPS
69  2016 CT Scan Does Not Differentiate Patients with Hepatopulmonary Syndrome from Other Patients with Liver Disease. ABRs
70  2016 Down-regulation of common NFkappaB-iNOS pathway by chronic Thalidomide treatment improves Hepatopulmonary Syndrome and Muscle Wasting in rats with Biliary Cirrhosis. BAL, HPAECs, sICAM-1
71  2016 Frequency of Hepatopulmonary Syndrome (HPS) Among Patients With Liver Cirrhosis: A Letter to Editor. ---
72  2016 Hepatopulmonary Syndrome and Liver Transplantation: A Recent Review of the Literature. A-a
73  2016 Hepatopulmonary Syndrome in Patients With Cystic Fibrosis and Liver Disease. CF
74  2016 Hepatopulmonary Syndrome: A Brief Review. A-a, IPVD, LT
75  2016 Hepatopulmonary syndrome: What we know and what we would like to know. IPVD, LT
76  2016 Inhibition of autophagy ameliorates pulmonary microvascular dilation and PMVECs excessive proliferation in rat experimental hepatopulmonary syndrome. 3-MA, CBDL, PMVECs
77  2016 International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension. POPH
78  2016 Intrapulmonary vascular dilation in children with chronic liver diseases: pre- and post-liver transplantation. CLD, IPVD, LT, SBT
79  2016 Mechanical characteristics of the pulmonary artery in beagle dogs with hepatopulmonary syndrome and portopulmonary hypertension. POPH
80  2016 Nitric oxide metabolites, nitrative stress, and paraoxonase activity in hepatopulmonary syndrome. CTR, ET, LC, NOx, NT, PONA
81  2016 Prevalence, Severity, and Prognostic Effect of Hepatopulmonary Syndrome in Liver Transplant Candidates. ESLD
82  2016 Pulmonary Arterial Hypertension Associated with Congenital Portosystemic Shunts Treated with Transcatheter Embolization and Pulmonary Vasodilators. PH, POPH
83  2016 Pulmonary complications of hepatic diseases. CLD, HH, PPH
84  2016 Quercetin alleviates pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. CBDL
85  2016 Role of splenic reservoir monocytes in pulmonary vascular monocyte accumulation in experimental hepatopulmonary syndrome. CBDL, VEGF-A
86  2016 The angiogenic related functions of bone marrow mesenchymal stem cells are promoted by CBDL rat serum via the Akt/Nrf2 pathway. BM-MSCs, CBDL, MSCs
87  2016 The Impact of Hypoxaemia on the Outcome in Liver Cirrhosis. ---
88  2016 The Role of TEE in Diagnosing Hepatopulmonary Syndrome and Cryptogenic Cirrhosis. ---
89  2016 [Hepatopulmonary syndrome]. ---
90  2016 [The hepatopulmonary syndrome]. ---
91  2015 A 45-Year-Old Undiagnosed Cirrhotic Patient with Hepatopulmonary Syndrome as First Presentation: A Case Report. ---
92  2015 A comparison of two common bile duct ligation methods to establish hepatopulmonary syndrome animal models. CBDL, MCBDL, UCBDL
93  2015 Abernethy syndrome, a rare cause of hypoxemia: A case report. CEPS II
94  2015 Aggravation of hepatopulmonary syndrome after sildenafil treatment in a patient with coexisting portopulmonary hypertension. PPHTN
95  2015 Bone morphogenic protein-2 regulates the myogenic differentiation of PMVECs in CBDL rat serum-induced pulmonary microvascular remodeling. BMP2, CBDL, IPVD, PMVECs
96  2015 Brain abscess in hepatopulmonary syndrome associated with biliary atresia. BA
97  2015 Caspase-3 inhibition prevents the development of hepatopulmonary syndrome in common bile duct ligation rats by alleviating pulmonary injury. AQP1, CBDL
98  2015 Clinical characteristics, predictors, and survival among patients with hepatopulmonary syndrome. ---
99  2015 Exercise capacity of cirrhotic patients with hepatopulmonary syndrome. HCV
100  2015 Extracorporeal membrane oxygenation after liver transplantation in a patient with hepatopulmonary syndrome and an atrial septal defect. ASD